195 clinical trials matched your search for Cancer. You can click one of the clinical trials below for more information, or click the Search Again button to enter different search text.

Search Again
Condition Study Title Investigator
Cancer Tissue Repository For The Collection of Hematologic Samples Suzanne Lentzsch, MD
Cancer Collecting and growing patient tumor and blood cells from extra tissue to learn about cancer and test new drugs Bret Taback, MD
Cancer Identification of Targets for Cancer Treatment Andrea Califano, PhD
Cancer Early Onset Malignancies Initiative (EOMI) Bret Taback, MD
Cancer Study of Atezolizumab in Alveolar Soft Part Sarcoma Prabhjot Mundi, MD
Cancer Study of Drug in Patients with Advanced Solid Malignancies and Lymphoma June Hou, MD
Cancer Clinical Trial Screening Tool to Address Cancer Health Disparities Katherine Crew, MD
Cancer A Study of MS-553 in Patients with Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL) Nicole Lamanna, MD
Cancer LAnreotide in Metastatic Pheochromocytoma / PARAganglioma (LAMPARA) Antonio Fojo, MD, PhD
Cancer Study of Ipilimumab, Cabozantinib, and Nivolumab in Rare Genitourinary Cancers (ICONIC) Mark Stein, MD
Cancer Study of IDE196 in Patients with Solid Tumors Shaheer Khan, DO
Cancer Study of A Vaccine Targeting Shared Neoantigens in Subjects with Advanced Solid Tumors Brian Henick, MD
Cancer Study of AMG510 in Subjects with Advanced Solid Tumors Benjamin Herzberg, MD
Cancer Study of Rituximab or Tocilizumab for Patients With Steroid-Dependent Immune-Related Adverse Events (irAEs) Brian Henick, MD
Cancer Safety Study of PBCAR0191 in Patients with Relapsed/Refractory Non-Hodgkin Lymphoma and r/r B-cell Acute Lymphoblastic Leukemia Ran Reshef, MD
Cancer TCR-engineered T Cells in Solid Tumors (ACTengine) Ran Reshef, MD
Cancer A Study of MORAb-202 in Participants With Selected Tumor Types June Hou, MD
Cancer Study of Safety and Tolerability of BCA101 Alone and in Combination With Pembrolizumab in Patients With EGFR-driven Advanced Solid Tumors Catherine Shu, MD
Cancer Study of ST101 in Patients with Advanced Solid Tumors Fabio Iwamoto, MD
Cancer Study of IMC-F106C Alone and in Combination With Checkpoint Inhibitors in Participants with Advanced Cancers Benjamin Izar, MD
Cancer A Study of ASP9801 in Patients With Advanced Metastatic Solid Tumors Matthew Ingham, MD
Cancer A Study of BMS-986340 Alone and in Combination With Nivolumab in Participants With Advanced Solid Tumors Shaheer Khan, DO
Cancer Nivolumab in Treating Patients With Autoimmune Disorders and Advanced, Metastatic, or Unresectable Cancer Brian Henick, MD
Cancer Study of AB928 in Combination with Other Therapies for Patients with Metastatic Colon Cancer (mCRC) Gulam Manji, MD, PhD
Cancer Study of Investigational Drug (RP-6306) in Patients with Advanced Cancer Ryan Moy, MD
Cancer Study of BAY 1895344 in Combination with Chemotherapy for Patients with Advanced Cancer Mark Stein, MD
Cancer Study of IV Contrast on Patients Going Through Image Guided Radiation Therapy (IGRT) for Abdominal and Pelvic Cancer David Horowitz, MD
Cancer Study of Isatuximab in Patients with Monoclonal Gammopathy of Renal Significance (MGRS) Divaya Bhutani, MD
Cancer Study of RP-3500 in Combination with PARP Inhibitor for Patients with Advanced Cancer Benjamin Herzberg, MD
Cancer Study of IDE397 in Patients with Advanced Solid Tumors Benjamin Herzberg, MD
Cancer Study of CS5001 in Patients with Advanced Solid Tumors Shaheer Khan, DO
Cancer Study of RP-6306 in Combination with FOLFIRI in Patients with Advanced Solid Tumors (Colon, Esophageal, or GI Cancer) Ryan Moy, MD
Cancer ACCESS: Study of Donor Blood Stem Cell Transplant in Patients with Multiple Myeloma, Leukemia, or Lymphoma Ran Reshef, MD
Cancer Study of BT7480 in Patients with Advanced Cancer Mark Stein, MD
Cancer Study of ASP3082 in Patients with Advanced Cancer with a KRAS G12D Mutation Benjamin Herzberg, MD
Cancer Study of STK-012 Alone or in Combination with Pembrolizumab (KEYTRUDA) in Patients with Advanced Solid Tumors Benjamin Izar, MD
Cancer Study of ISIS 702843 in Patients with Phlebotomy-Dependent Polycythemia Vera (PD-PV) Joseph Jurcic, MD
Cancer Study of 68Ga-FAP-2286 and 177Lu-FAP-2286 in Patients with Advanced Cancer Ryan Moy, MD
Cancer Study of E-602 Alone or in Combination with Libtayo (Cemiplimab) in Patients with Advanced Cancer Brian Henick, MD
Cancer Study of BLU-222 Alone or in Combination with Other Cancer Therapy for Patients with Advanced Cancer Brian Henick, MD
Cancer Study of LNS8801 Alone or in Combination with Pembrolizumab in Patients with Advanced Cancer Brian Henick, MD
Cancer Study of RMC-6291 in Patients with Advanced Solid Tumors Benjamin Herzberg, MD
Cancer Study of Gavo-Cel Alone or in Combination with Nivolumab or Ipilimumab in Patients with Advanced Cancer Ran Reshef, MD
Cancer Study of ASKG915 in Patients with Advanced Solid Tumors Mark Stein, MD
Cancer Study of XL092 Alone or in Combination with Anticancer Therapy in Patients with Unresectable orMetastatic Solid Tumors Karie D. Runcie, MD
Cancer Study of MRT-2359 in Patients with Solid Tumors Benjamin Herzberg, MD
Cancer Study of RMC-6236 in Patients with Solid Tumors with a KRAS Mutation Benjamin Herzberg, MD
Cancer Study of BGB-16673 in Patients with Leukemia or Lymphoma Nicole Lamanna, MD
Breast Cancer Study to Predict Your Therapeutic Response (I-SPY 2 Trial) Meghna Trivedi, MD
Breast Cancer Study Comparing Survival of Patients Monitored with Serum Tumor Marker Directed Disease Versus Usual Care in Metastatic Breast Cancer Melissa Accordino, MD
Breast Cancer Addinex-Opioid Dispenser for Post-Op Pain in Cancer Patients Dawn Hershman, MD
Breast Cancer MiChoice: Making Informed Choices on Incorporating Chemoprevention Into Care Katherine Crew, MD
Breast Cancer Study of Symptom Monitoring using Young, Empowered & Strong (YES) Web Portal for Breast Cancer Survivors Dawn Hershman, MD
Breast Cancer Study of Eribulin in Combination with Copanlisib in Patients with Metastatic Triple-Negative Breast Cancer Meghna Trivedi, MD
Breast Cancer Decreasing Chemotherapy for HER2 Breast Cancer Patients After Pre-surgery Chemo and Targeted Therapy Julia McGuinness, MD
Breast Cancer Study of T-DM1 in Combination with Tucatinib for Patients with HER2-Positive Breast Cancer Julia McGuinness, MD
Breast Cancer Intervention to Improve Medication Scheduling for Patients with Breast Cancer Dawn Hershman, MD
Breast Cancer Study of RLY-2608 in Patients with Breast Cancer Julia McGuinness, MD
Breast Cancer Study of Radiation Therapy Alone or in Combination With Olaparib for Patients with Inflammatory Breast Cancer (IBC) Eileen Connolly, MD, PhD
Breast Cancer Study of GLSI-100 in Female Patients with Breast Cancer Julia McGuinness, MD
Breast Cancer Study of Denosumab in Women with Breast Cancer who Carry the BRCA1 Mutation Katherine Crew, MD
Breast Cancer Study of Drug - LY3484356 in Patients with Breast Cancer (ER+, HER2-) Meghna Trivedi, MD
Breast Cancer Study of Sacituzumab Govitecan (TRODELVY) in Patients with Triple-Negative Breast Cancer (TNBC) Meghna Trivedi, MD
Breast Cancer Study of Sacituzumab Govitecan in Combination with Pembrolizumab vs. Chemotherapy in Patients with Advanced Triple-Negative Breast Cancer Meghna Trivedi, MD
Breast Cancer Study of Breast Cancer in Black Women Lauren Houghton, PhD
Breast Cancer Study of Breast Cancer in Black Women - Healthy Controls Lauren Houghton, PhD
Breast Cancer Tele-IPT vs. Tele-Pharmacotherapy for Depression in Patients with Non-Metastatic Breast Cancer John Markowitz, MD
Multiple Myeloma Study of bb2121 in Subjects With Relapsed and Refractory Multiple Myeloma and in Subjects With High-Risk Multiple Myeloma (KarMMa-2) Ran Reshef, MD
Multiple Myeloma First in Human (FIH) Study of REGN5458 in Patients With Relapsed or Refractory Multiple Myeloma Suzanne Lentzsch, MD
Multiple Myeloma Safety and Efficacy of Bb2121 (Ide-cel) Combinations in Patients with Multiple Myeloma (KarMMa-7) Ran Reshef, MD
Multiple Myeloma Study of Isatuximab in Patients with Multiple Myeloma or Lymphoma who are Recovering from Stem Cell Transplant Divaya Bhutani, MD
Multiple Myeloma Study of Daratumumab in Addition to Chemotherapy for Patients with Smoldering Multiple Myeloma (SMM) Rajshekhar Chakraborty, MD
Multiple Myeloma Study of VRd Followed by Cilta-cel vs. VRd Followed by Rd Therapy in Patients with Newly Diagnosed Multiple Myeloma Ran Reshef, MD
Multiple Myeloma Study of Venetoclax in Combination with Dexamethasone in Patients with Light Chain Amyloidosis Rajshekhar Chakraborty, MD
Multiple Myeloma Study of STI-6129 in Patients with Relapse/Refractory Multiple Myeloma (RRMM) Rajshekhar Chakraborty, MD
Skin Cancer Study of RP1 in Organ Transplant Patients with Skin Cancer Shaheer Khan, DO
Liver Cancer A 5-Year Study of the Natural History and Management of Patients with Hepatocellular Carcioma (A Type of Liver Cancer) Elizabeth Verna, MD
Lymphoma Study of Drug for Solid Organ Transplant Subjects with Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease Ran Reshef, MD
Lymphoma Study of Tazemetostat or Placebo with Lenalidomide plus Rituximab in Subjects With Relapsed/Refractory Follicular Lymphoma Jennifer Amengual, MD
Lymphoma Study of LOXO-305 in Patients with Mantle Cell Lymphoma (MCL) Andrew Lipsky, MD
Lymphoma Study of Isatuximab in Patients with Multiple Myeloma or Lymphoma who are Recovering from Stem Cell Transplant Divaya Bhutani, MD
Lymphoma Study of CC-486 (Oral Azacitidine) Alone or in Combination with Chemo in Participants with Diffuse Large B Cell Lymphoma (DLBCL) (Ages 75+) Jennifer Amengual, MD
Lymphoma Study of TAK-007 in Patients with Non-Hodgkin Lymphoma Ran Reshef, MD
Lymphoma Study of Duvelisib or Azacitidine in Addition to Chemotherapy in Patients with Peripheral T-Cell Lymphoma (PTCL) Jennifer Amengual, MD
Lymphoma Study of Lenalidomide in Combination with Chemotherapy in Patients with HTLV-Associated Adult T-Cell Leukemia-Lymphoma (ATLL) Jennifer Amengual, MD
Lymphoma Study of Axicabtagene Ciloleucel (Axi-Cel) in Patients with Follicular Lymphoma Ran Reshef, MD
Lymphoma Study of STK-009 in Combination with SYNCAR-001 in Patients with Lymphoma or Leukemia Ran Reshef, MD
Lymphoma Study of Tazemetostat in Combination with Belinostat in Patients with Relapsed or Refractory Lymphoma Jennifer Amengual, MD
Lymphoma Study of ONO-4685 in Patients with T-Cell Lymphoma Barbara Pro, MD
Lymphoma Study of Axi-cel vs. Chemotherapy in Patients with High-Risk Large B-Cell Lymphoma Ran Reshef, MD
Lung Cancer Study of Therapies in Participants with Resectable (removable) and Untreated Non-Small Cell Lung Cancer (NSCLC) Catherine Shu, MD
Lung Cancer Testing Whether the Use of Brain Scans Alone vs. Brain Scans Plus Brain Radiation Affects Lifespan in Patients With Small Cell Lung Cancer Simon Cheng, MD, PhD
Lung Cancer Study of Combining Osimertinib with and without Ramucirumab in Non-Small Cell Lung Cancer (NSCLC) Catherine Shu, MD
Lung Cancer Tomivosertib With Anti-PD-(L)1 in Subjects With Non-Small Cell Lung Cancer (NSCLC) Brian Henick, MD
Lung Cancer Study of Osimertinib (TAGRISSOTM) in Non-Small Cell Lung Cancer (NeoADAURA) Patients Catherine Shu, MD
Lung Cancer Study of Atezolizumab and Tiragolumab Alone or in Combination with Chemotherapy in Patients with Non-Small Cell Lung Cancer (NSCLC) Catherine Shu, MD
Lung Cancer Study in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC) whose Disease has Gotten Worse After Osermitinib Treatment Catherine Shu, MD
Lung Cancer Study of Pembrolizumab Alone or in Combination with Chemotherapy in Older Patients with Non-Small Cell Lung Cancer Catherine Shu, MD
Lung Cancer Liver-Directed Radiotherapy Along with Chemotherapy for Patients with Extensive Stage Small Cell Lung Cancer (ES-SCLC) and Liver Metastases Brian Henick, MD
Lung Cancer Study of Berzosertib Compared to Chemotherapy for Patients with Non-Small Cell Lung Cancer Benjamin Herzberg, MD
Lung Cancer ApricityCare: Smartphone App Study for Patients with Non-Small Cell Lung Cancer (NSCLC) Brian Henick, MD
Lung Cancer Study of Savolitinib in Combination with Osimertinib vs. Chemotherapy in Patients with Non-Small Cell Lung Cancer (NSCLC) Catherine Shu, MD
Lung Cancer Study of Patritumab Deruxtecan in Combination with Osimertinib in Patients with Non-Small Cell Lung Cancer (NSCLC) Catherine Shu, MD
Gynecologic Cancer Study of REGN4018 Alone or in Combination with Cemiplimab in Patients with Ovarian Cancer June Hou, MD
Gynecologic Cancer Study of SL-172154 in Combination with PLD or MIRV in Patients with Ovarian Cancer June Hou, MD
Gynecologic Cancer Study of Upifitamab Rilsodotin (XMT-1536) in Patients with Recurrent Ovarian Cancer Jason Wright, MD
Gynecologic Cancer Study of XmAb20717 in Patients with Gynecological Cancer (Cervical, Ovarian, or Endometrial) June Hou, MD
Gynecologic Cancer Comparing Investigational Surgery to Laparotomy After Chemotherapy in Women with Epithelial Ovarian Cancer (EOC) Jason Wright, MD
Gynecologic Cancer Comparing Surgeries to Reduce the Risk of Ovarian Cancer in Women with BRCA1 Mutations Jason Wright, MD
Gynecologic Cancer Study of Abemaciclib in Combination with Letrozole in Women with Endometrial Cancer Jason Wright, MD
Gynecologic Cancer Study of MORAb-202 in Women with Ovarian, Fallopian, or Primary Peritoneal Cancer (PPC) June Hou, MD
Gynecologic Cancer Study of ZN-c3 in Patients with Solid Tumors with MRE11, RAD50, NBN, or CCNE1 Gene Mutations June Hou, MD
Solid Tumors Study of Drug Alone and In Combination with Nivolumab in Advanced Solid Tumors Brian Henick, MD
Solid Tumors Study of ASTX295 in Patients With Solid Tumors Fabio Iwamoto, MD
Solid Tumors A Study of XmAb23104 in Subjects With Selected Advanced Solid Tumors (DUET-3) Mark Stein, MD
Pancreatic Cancer The Cancer of the Pancreas Screening-5 Study (CAPS5 Study) Fay Kastrinos, MD
Pancreatic Cancer Study of Multiple Treatment Combinations in Patients with Metastatic Pancreatic Ductal Adenocarcinoma (Morpheus-Pancreatic Cancer) Gulam Manji, MD, PhD
Pancreatic Cancer Study of Stimulation with Bethanechol in Pancreatic Adenocarcinoma Prior to Surgery Susan Bates, MD
Pancreatic Cancer Chemo4METPANC: Combination Chemotherapy (Gemcitabine and Nab-Paclitaxel), Motixafortide, and Cemiplimab in Pancreas Adenocarcinoma Gulam Manji, MD, PhD
Pancreatic Cancer Registry Study to Evaluate the Nanoknife System in Treating Stage 3 Pancreatic Adenocarcinoma Michael Kluger, MD, MPH
Pancreatic Cancer Gemcitabine vs. IV Gemcitabine and Nab-Paclitaxel Following Radiotherapy for Locally Advanced Pancreatic Cancer (TIGeR-PaC) Susan Bates, MD
Pancreatic Cancer Study of Bethanechol in Combination with Chemotherapy for Patients with Pancreatic Cancer Susan Bates, MD
Pancreatic Cancer Study of Drug - SBP-101 Alone or in Combination with Chemotherapy in Patients with Untreated Pancreatic Ductal Adenocarcinoma (PDAC) Gulam Manji, MD, PhD
Leukemia Study of Nivolumab in Combination with 5-Azacytidine in Acute Myeloid Leukemia (AML) - Children and Adults Age 1 to 30 Nobuko Hijiya, MD
Leukemia Study of Panzyga in Primary Infection Prophylaxis (Prevention) in Patients with Chronic Lymphocytic Leukemia (PRO-SID) Nicole Lamanna, MD
Leukemia Study of BGB-11417 in Patients with Leukemia Nicole Lamanna, MD
Leukemia Study for Patients with Chronic Lymphocytic Leukemia (CLL) who are Currently Receiving Treatment with Venetoclax Nicole Lamanna, MD
Leukemia Study of TSC 100 & TSC 101 in Patients with Leukemia Undergoing Haploidentical Allogeneic Blood Stem Cell Transplantation (HCT) Ran Reshef, MD
Leukemia Study of Fedratinib in Combination with Chemotherapy in Patients with Myeloproliferative Neoplasm (MPN) in Accelerated and Blast Phase Joseph Jurcic, MD
Leukemia Study of Pirtobrutinib (LOXO-305) Alone or in Combination With Chemotherapy in Patients with Chronic Lymphocytic Leukemia (CLL) Nicole Lamanna, MD
Leukemia Study of Venetoclax and Azacitidine After Allogeneic Stem Cell Transplantation in Patients with Acute Myeloid Leukemia (AML) Ran Reshef, MD
Leukemia Study of Polatuzumab Vedotin in Combination with Chemotherapy in Subjectswith Richter's Transformation Andrew Lipsky, MD
Leukemia Study of BLU-263 in Patients with Indolent Systemic Mastocytosis (ISM) or Monoclonal Mast Cell Activation Syndrome (mMCAS) Joseph Jurcic, MD
Leukemia Study of Drug - DSP-5336 in Patients with Leukemia Joseph Jurcic, MD
Leukemia Study of Magrolimab in Combination with Chemotherapy in Patients with Acute Myeloid Leukemia (AML) Joseph Jurcic, MD
Leukemia Study of STK-009 in Combination with SYNCAR-001 in Patients with Lymphoma or Leukemia Ran Reshef, MD
Leukemia Study of Etavopivat in Patients with Myelodysplastic Syndromes (MDS) Joseph Jurcic, MD
Leukemia Study of VOR33 in Patients with Acute Myeloid Leukemia (AML) Markus Mapara, MD
Leukemia Study of Quizartinib in Combination with Chemotherapy for Children and Young Adults with Recurrent /Refractory Acute Myeloid Leukemia (AML) Nobuko Hijiya, MD
Leukemia Study of SEA-CD70 in Patients with Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS) Joseph Jurcic, MD
Bladder Cancer ADAPT-BLADDER: Modern Immunotherpy in BCG-Relapsing Urothelial Carcinoma of the Bladder Christopher Anderson, MD
Gastrointestinal Study of RO7198457 for Patients Who Have Had Surgery for Stage II and Stage III Colon Cancer Yoanna Pumpalova, MD
Gastrointestinal Study of Pembrolizumab Alone or in Combination with Encorafenib and Cetuximab in Patients with Colon Cancer Yoanna Pumpalova, MD
Gastrointestinal Study of Domvanalimab and Zimberelimab Alone or in Combination with Chemotherapy in Patients with Upper Gastrointestinal Cancers (UGI) Ryan Moy, MD
Gastrointestinal Study of DKN-01 in Combination with Tislelizumab & Chemotherapy in Patients with Advanced Gastric or Gastroesophageal Junction (GEJ) Cancer Ryan Moy, MD
Prostate Cancer IRONMAN: International Registry for Men with Advanced Prostate Cancer Mark Stein, MD
Prostate Cancer Study of ADXS-504 in Patients with Prostate Cancer Mark Stein, MD
Prostate Cancer Study of XmAb20717 Alone or in Combination with Chemotherapy in Patients with Prostate Cancer Mark Stein, MD
Prostate Cancer Study of Cabozantinib in Patients with Prostate Cancer who Previously Received Anti-Androgen Therapy Mark Stein, MD
Prostate Cancer Study of CC-94676 in Patients with Metastatic Castration-Resistant Prostate Cancer (mCRPC) Karie D. Runcie, MD
Prostate Cancer Study of JNJ-78278343 in Patients with Advanced Prostate Cancer Mark Stein, MD
Prostate Cancer Study of Lutetium-177 PSMA I&T in Patients with Castration-Resistant Prostate Cancer Mark Stein, MD
Prostate Cancer Study of Whole-Food Plant-Based Diet (WFPBD) to Control Weight in Overweight/Obese Men with Prostate Cancer Mark Stein, MD
Prostate Cancer Study of VTP-850 in Male Patients with Prostate Cancer Whose Prostate-Specific Antigen (PSA) Levels Have Risen Mark Stein, MD
Kidney Cancer Study of Experimental Drug (Axitinib) in Patients with Metastatic Pheochromocytoma (PCC) or Paraganglioma Antonio Fojo, MD, PhD
Kidney Cancer Study of Spartalizumab and Canakinumab Prior to Radical Nephrectomy in Patients with Localized Clear Cell Renal Cell Carcinoma Karie D. Runcie, MD
Kidney Cancer Cyto-KIK Trial: CYTO Reductive Surgery in Kidney Cancer Plus Immunotherapy and Targeted Kinase Inhibition Mark Stein, MD
Kidney Cancer Study of XmAb819 in Patients with Clear Cell Renal Cell Carcinoma Karie D. Runcie, MD
Sarcoma A Study for Patients with Malignant Peripheral Nerve Sheath Tumors Using Study Drugs PLX3397 and Sirolimus Gulam Manji, MD, PhD
Sarcoma Study of Belinostat and Guadecitabine for Treatment of Chondrosarcoma Shaheer Khan, DO
Sarcoma A Study of AL102 in Patients With Progressing Desmoid Tumors (RINGSIDE) Prabhjot Mundi, MD
Sarcoma Study of INBRX 109 in Patients with Metastatic or Inoperable Chondrosarcoma Shaheer Khan, DO
Sarcoma Study of AGEN1181 Alone or in Combination with Balstilimab in Patients with Advanced Sarcoma Brian Henick, MD
Sarcoma Study of Drug - CFT8634 in Patients with Synovial Sarcoma or SMARCB1-Null Tumors Shaheer Khan, DO
Sarcoma Study of Unesbulin in Patients with Leiomyosarcoma (LMS) Prabhjot Mundi, MD
Uveal Melanoma A Prospective Natural History Study in Uveal Melanoma Shaheer Khan, DO
Brain Cancer Study to Evaluate Multiple Treatments for Patients with Newly Diagnosed or Recurrent GBM Andrew Lassman, MD
Brain Cancer Study of Tumor Treating Fields (Optune, 200kHz) with Radiation Therapy and Temozolomide for the Treatment of Newly Diagnosed Glioblastoma Fabio Iwamoto, MD
Brain Cancer ImmuneSense Study: IGV-001 in Newly Diagnosed Patients With Glioblastoma Brian Gill, MD
Brain Cancer Study of Chemotherapy Drug, Lomustine, in Addition to Temozolomide in Patients with Glioblastoma (GBM) Fabio Iwamoto, MD
Brain Cancer Study of Immune Therapy Drugs in Addition to the Usual Radiation Therapy for Patients with Brain Cancer (Glioblastoma) Fabio Iwamoto, MD
Brain Cancer Study of Vaccine for Cytomegalovirus (CMV) in Patients with Brain Tumors Andrew Lassman, MD
Brain Cancer Study of Focused Ultrasound (FUS) with DEFINITY Microbubbles in Children and Young Adults with Progressive Diffuse Midline Glioma (DMG) Cheng-Chia Wu, MD
Brain Cancer Study of Tirabrutinib in Patients with Primary Central Nervous System Lymphoma (PCNSL) Fabio Iwamoto, MD
Brain Cancer Study of DSP-0390 in Patients with Recurrent High-Grade Glioma Mary Welch, MD
Brain Cancer Study of Safusidenib in Patients with Brain Glioma Fabio Iwamoto, MD
Brain Tumors Study to Evaluate Multiple Treatments for Patients with Newly Diagnosed or Recurrent GBM Andrew Lassman, MD
Childhood Leukemia Study of Nivolumab in Combination with 5-Azacytidine in Acute Myeloid Leukemia (AML) - Children and Adults Age 1 to 30 Nobuko Hijiya, MD
Brain Tumors Study of Tumor Treating Fields (Optune, 200kHz) with Radiation Therapy and Temozolomide for Treatment of Newly Diagnosed Glioblastoma Fabio Iwamoto, MD
Squamous Cell Carcinoma Study of Ruxolitinib in Solid Organ Transplant Recipients with Advanced Cutaneous Squamous Cell Carcinoma Alexander Wei, MD
Autoimmune Disorders Nivolumab in Treating Patients With Autoimmune Disorders and Advanced, Metastatic, or Unresectable Cancer Brian Henick, MD
Brain Tumors ImmuneSense Study: IGV-001 in Newly Diagnosed Patients With Glioblastoma Brian Gill, MD
Melanoma Study of SD-101 in Patients with Metastatic Uveal Melanoma (Eye Cancer) with Liver Disease Alexander Wei, MD
Depression Tele-IPT vs. Tele-Pharmacotherapy for Depression in Patients with Non-Metastatic Breast Cancer John Markowitz, MD
Brain Tumors Study of Chemotherapy Drug, Lomustine, in Addition to Temozolomide in Patients with Glioblastoma (GBM) Fabio Iwamoto, MD
Melanoma Study of ALKS 4230 in Patients with Previously Treated Advanced Melanoma Benjamin Izar, MD
Brain Tumors Study of Immune Therapy Drugs in Addition to the Usual Radiation Therapy for Patients with Brain Cancer (Glioblastoma) Fabio Iwamoto, MD
Melanoma Study of DYP688 in Patients with Melanoma Shaheer Khan, DO
Healthy Volunteers Columbia University Biobank at New York Presbyterian (CUB-NYP) Muredach Reilly, MD
Brain Tumors Study of Tirabrutinib in Patients with Primary Central Nervous System Lymphoma (PCNSL) Fabio Iwamoto, MD
Brain Tumors Study of DSP-0390 in Patients with Recurrent High-Grade Glioma Mary Welch, MD
Melanoma Study of Fianlimab and Cemiplimab vs. Pembrolizumab in Patients with Resected High-Risk Melanoma Benjamin Izar, MD
Endocrine & Metabolic Disease Temporary Insulin Resistance Joshua Cook, MD, PhD
Diabetes Temporary Insulin Resistance Joshua Cook, MD, PhD
Healthy Volunteers Temporary Insulin Resistance Joshua Cook, MD, PhD